DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main »

Mineralys Therapeutics shares owned by DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main from 13F filings

Historical chart of DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.1M 112k 36.29

More positions owned by DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main

NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Bank of America Corporation (BAC)
Thermo Fisher Scientific (TMO)
Abbvie (ABBV)
American Express Company (AXP)
Wal-Mart Stores (WMT)
Meta Platforms Cl A (META)
Boston Scientific Corporation (BSX)
Alphabet Cap Stk Cl C (GOOG)

View all positions for DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main

Top funds holding Mineralys Therapeutics

Catalys Pacific
RA Capital Management
Samsara BioCapital
Caligan Partners
BlackRock
Vanguard Group
State Street Corporation
Caption Management
Citadel Advisors
FMR
Franklin Resources
Laurion Capital Management
Boothbay Fund Management
Holocene Advisors
Sr One Capital Management

View all funds holding Mineralys Therapeutics